Cargando…

Health utility of children with acute lymphoblastic leukemia in China

BACKGROUND: Acute lymphoblastic leukemia is the most common cancer in children. As the 5-year survival rate has been improved to over 80%, more emphasis is now placed on reducing therapy toxicities and enhancing health-related quality of life (HRQoL) of patients during treatment. Our objective was t...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Wei, Dong, Yaqi, Ji, Mingjing, Zhang, Xiaoyan, Cai, Jiaoyang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9846596/
https://www.ncbi.nlm.nih.gov/pubmed/36684921
http://dx.doi.org/10.3389/fpubh.2022.1069336
_version_ 1784871222364864512
author Wang, Wei
Dong, Yaqi
Ji, Mingjing
Zhang, Xiaoyan
Cai, Jiaoyang
author_facet Wang, Wei
Dong, Yaqi
Ji, Mingjing
Zhang, Xiaoyan
Cai, Jiaoyang
author_sort Wang, Wei
collection PubMed
description BACKGROUND: Acute lymphoblastic leukemia is the most common cancer in children. As the 5-year survival rate has been improved to over 80%, more emphasis is now placed on reducing therapy toxicities and enhancing health-related quality of life (HRQoL) of patients during treatment. Our objective was to measure health utility of pediatric acute lymphoblastic leukemia (pALL) patients in China, examine utility weights of different treatment phases and influencing factors of health utility, as well as identify which aspects of HRQoL were most impaired. METHODS: A cross-sectional study was conducted in Shanghai Children's Medical Center (SCMC) Affiliated to Shanghai Jiao Tong University School of Medicine in China from April to November 2021. Primary caregivers of 247 patients completed the assessment by CHU9D-CHN and health utility scores were computed for all the patients and stratified by treatment phases. Various multivariable models were constructed and the best was chosen to identify independent factors associated with utility scores. Factors affecting the most impaired dimensions were also examined. RESULTS: The overall mean (SD) health utility score was 0.79 (±0.17) and significantly increased from induction (0.73 [±0.19], P < 0.001) to consolidation (0.74 [±0.18]), and to maintenance (0.82 [±0.16]). After adjusting for potentially influencing factors, utility scores in induction (Beta = −0.086, P = 0.005) and consolidation (Beta = −0.074, P = 0.043) were constantly lower than those during maintenance. In item-level analysis, lower age and induction phase were found to be significantly associated with high severity reported on the “school work/homework” dimension. Additionally, only the induction phase (vs. maintenance, OR = 2.24, P = 0.016) was independently associated with the high severity level reported on the “able to join in activities” dimension. CONCLUSIONS: This is the first study that measured health utility of children with pALL in China. Mean health utility scores increased from induction to maintenance. These provided important utility estimates that help inform future health economic models. The phrasing of “School work/homework” in CHU9D-CHN could be further improved. More efforts are needed to design and implement specific interventions targeting at the dimension “able to join in activities” for enhancing HRQoL of children with pALL in China.
format Online
Article
Text
id pubmed-9846596
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-98465962023-01-19 Health utility of children with acute lymphoblastic leukemia in China Wang, Wei Dong, Yaqi Ji, Mingjing Zhang, Xiaoyan Cai, Jiaoyang Front Public Health Public Health BACKGROUND: Acute lymphoblastic leukemia is the most common cancer in children. As the 5-year survival rate has been improved to over 80%, more emphasis is now placed on reducing therapy toxicities and enhancing health-related quality of life (HRQoL) of patients during treatment. Our objective was to measure health utility of pediatric acute lymphoblastic leukemia (pALL) patients in China, examine utility weights of different treatment phases and influencing factors of health utility, as well as identify which aspects of HRQoL were most impaired. METHODS: A cross-sectional study was conducted in Shanghai Children's Medical Center (SCMC) Affiliated to Shanghai Jiao Tong University School of Medicine in China from April to November 2021. Primary caregivers of 247 patients completed the assessment by CHU9D-CHN and health utility scores were computed for all the patients and stratified by treatment phases. Various multivariable models were constructed and the best was chosen to identify independent factors associated with utility scores. Factors affecting the most impaired dimensions were also examined. RESULTS: The overall mean (SD) health utility score was 0.79 (±0.17) and significantly increased from induction (0.73 [±0.19], P < 0.001) to consolidation (0.74 [±0.18]), and to maintenance (0.82 [±0.16]). After adjusting for potentially influencing factors, utility scores in induction (Beta = −0.086, P = 0.005) and consolidation (Beta = −0.074, P = 0.043) were constantly lower than those during maintenance. In item-level analysis, lower age and induction phase were found to be significantly associated with high severity reported on the “school work/homework” dimension. Additionally, only the induction phase (vs. maintenance, OR = 2.24, P = 0.016) was independently associated with the high severity level reported on the “able to join in activities” dimension. CONCLUSIONS: This is the first study that measured health utility of children with pALL in China. Mean health utility scores increased from induction to maintenance. These provided important utility estimates that help inform future health economic models. The phrasing of “School work/homework” in CHU9D-CHN could be further improved. More efforts are needed to design and implement specific interventions targeting at the dimension “able to join in activities” for enhancing HRQoL of children with pALL in China. Frontiers Media S.A. 2023-01-04 /pmc/articles/PMC9846596/ /pubmed/36684921 http://dx.doi.org/10.3389/fpubh.2022.1069336 Text en Copyright © 2023 Wang, Dong, Ji, Zhang and Cai. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Public Health
Wang, Wei
Dong, Yaqi
Ji, Mingjing
Zhang, Xiaoyan
Cai, Jiaoyang
Health utility of children with acute lymphoblastic leukemia in China
title Health utility of children with acute lymphoblastic leukemia in China
title_full Health utility of children with acute lymphoblastic leukemia in China
title_fullStr Health utility of children with acute lymphoblastic leukemia in China
title_full_unstemmed Health utility of children with acute lymphoblastic leukemia in China
title_short Health utility of children with acute lymphoblastic leukemia in China
title_sort health utility of children with acute lymphoblastic leukemia in china
topic Public Health
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9846596/
https://www.ncbi.nlm.nih.gov/pubmed/36684921
http://dx.doi.org/10.3389/fpubh.2022.1069336
work_keys_str_mv AT wangwei healthutilityofchildrenwithacutelymphoblasticleukemiainchina
AT dongyaqi healthutilityofchildrenwithacutelymphoblasticleukemiainchina
AT jimingjing healthutilityofchildrenwithacutelymphoblasticleukemiainchina
AT zhangxiaoyan healthutilityofchildrenwithacutelymphoblasticleukemiainchina
AT caijiaoyang healthutilityofchildrenwithacutelymphoblasticleukemiainchina